Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

TP53 single nucleotide polymorphism rs1042522 in salivary gland neoplasms.

Gomes CC, Fonseca-Silva T, Diniz MG, Orsine LA, Gomez RS.

Head Neck. 2014 Dec;36(12):1685-8. doi: 10.1002/hed.23513. Epub 2014 Jan 13.

PMID:
24115240
2.

Anti-apoptotic gene transcription signature of salivary gland neoplasms.

Gomes CC, Bernardes VF, Diniz MG, De Marco L, Gomez RS.

BMC Cancer. 2012 Feb 7;12:61. doi: 10.1186/1471-2407-12-61.

3.

Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients.

Carvalho RM, Pinto GR, Yoshioka FK, Lima PD, Souza CR, Guimarães AC, Lamarão LM, Rey JA, Burbano RR.

J Neurooncol. 2012 Oct;110(1):49-57. doi: 10.1007/s11060-012-0950-0. Epub 2012 Aug 11.

PMID:
22886512
4.

Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.

Granja F, Morari J, Morari EC, Correa LA, Assumpção LV, Ward LS.

Cancer Lett. 2004 Jul 16;210(2):151-7.

PMID:
15183530
5.

TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.

Jha P, Jha P, Pathak P, Chosdol K, Suri V, Sharma MC, Kumar G, Singh M, Mahapatra AK, Sarkar C.

Exp Mol Pathol. 2011 Apr;90(2):167-72. doi: 10.1016/j.yexmp.2010.11.002. Epub 2010 Nov 27.

PMID:
21115003
6.

TP53 codon 72 polymorphism in oral squamous cell carcinoma.

Drummond SN, De Marco L, Pordeus Ide A, Barbosa AA, Gomez RS.

Anticancer Res. 2002 Nov-Dec;22(6A):3379-81.

PMID:
12530090
7.

CXCL12 G801A polymorphism is associated with an increased risk of benign salivary gland tumors in the Chinese population.

Liu W, Zhu E, Wang R, Wang L, Liu T.

Med Oncol. 2012 Jun;29(2):677-81. doi: 10.1007/s12032-011-9838-7. Epub 2011 Feb 5.

PMID:
21298365
8.

Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.

Chen K, Hu Z, Wang LE, Sturgis EM, El-Naggar AK, Zhang W, Wei Q.

Carcinogenesis. 2007 Sep;28(9):2008-12. Epub 2007 Aug 11.

PMID:
17693666
9.

[TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].

Cañas M, Morán Y, Camargo ME, Rivero MB, Bohórquez A, Villegas V, Ramírez E, Rendón Y, Suárez A, Morales L, Useche E, Salazar S, Zambrano A, Ramírez A, Valderrama E, Briceño Z, Chiurillo MA.

Invest Clin. 2009 Jun;50(2):153-61. Spanish.

PMID:
19662811
10.

Tumor suppressor gene TP53 is genetically associated with schizophrenia in the Chinese population.

Yang Y, Xiao Z, Chen W, Sang H, Guan Y, Peng Y, Zhang D, Gu Z, Qian M, He G, Qin W, Li D, Gu N, He L.

Neurosci Lett. 2004 Oct 14;369(2):126-31.

PMID:
15450681
11.

Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.

Hadhri-Guiga B, Toumi N, Khabir A, Sellami-Boudawara T, Ghorbel A, Daoud J, Frikha M, Gargouri A, Mokdad-Gargouri R.

Cancer Genet Cytogenet. 2007 Oct 15;178(2):89-93.

PMID:
17954263
12.

Impact of single-nucleotide polymorphisms at the TP53-binding and responsive promoter region of BCL2 gene in modulating the phenotypic variability of LGMD2C patients.

Hadj Salem I, Kamoun F, Louhichi N, Trigui M, Triki C, Fakhfakh F.

Mol Biol Rep. 2012 Jul;39(7):7479-86. doi: 10.1007/s11033-012-1581-4. Epub 2012 Feb 25.

PMID:
22367371
13.

[Association of p53 gene polymorphism with susceptibility to ovarian cancer].

Kang S, Duan LH, Zhang JH, Guo W, Wang N, Li Y.

Zhonghua Fu Chan Ke Za Zhi. 2004 Nov;39(11):754-8. Chinese.

PMID:
15634502
14.

Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.

Cortezzi SS, Provazzi PJ, Sobrinho JS, Mann-Prado JC, Reis PM, de Freitas SE, Filho JF, Fukuyama EE, Cordeiro JA, Cury PM, Maniglia JV, Villa LL, Tajara EH, Rahal P.

Cancer Genet Cytogenet. 2004 Apr 1;150(1):44-9.

PMID:
15041222
15.

Association of TP53 codon 72 polymorphism with susceptibility to ovarian carcinomas in Serbian women.

Malisic EJ, Jankovic RN, Jakovljevic KV, Radulovic SS.

Eur J Obstet Gynecol Reprod Biol. 2013 Jan;166(1):90-3. doi: 10.1016/j.ejogrb.2012.10.002. Epub 2012 Oct 23.

PMID:
23092908
16.
17.

Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.

To-Figueras J, Gene M, Gomez-Catalan J, Galan C, Firvida J, Fuentes M, Rodamilans M, Huguet E, Estape J, Corbella J.

Cancer Epidemiol Biomarkers Prev. 1996 May;5(5):337-42.

18.

The Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk.

Proestling K, Hebar A, Pruckner N, Marton E, Vinatzer U, Schreiber M.

PLoS One. 2012;7(10):e47325. doi: 10.1371/journal.pone.0047325. Epub 2012 Oct 10.

19.

The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project.

Pastor-Idoate S, Rodriguez-Hernández I, Rojas J, Fernández I, García-Gutierrez MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon Y, Harsum S, Maclaren RE, Charteris D, van Meurs J, González-Sarmiento R, Pastor JC; Genetics on PVR Study Group..

Ophthalmology. 2013 Mar;120(3):623-8. doi: 10.1016/j.ophtha.2012.08.019. Epub 2012 Dec 1.

PMID:
23207172
20.

TP53 mutations in salivary gland neoplasms.

Matizonkas-Antonio LF, de Mesquita RA, de Souza SC, Nunes FD.

Braz Dent J. 2005;16(2):162-6.

PMID:
16475613

Supplemental Content

Support Center